Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats

[1]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Di Chiara,et al.  Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[3]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[4]  P. Johansen,et al.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  G. Gessa,et al.  Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. , 1987, European journal of pharmacology.

[6]  J. B. Justice,et al.  Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. , 1987, European journal of pharmacology.

[7]  G. Di Chiara,et al.  Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. , 1987, European journal of pharmacology.

[8]  B. Westerink,et al.  Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. , 1987, European journal of pharmacology.

[9]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[10]  G. Chiara,et al.  Preferential Stimulation of Dopamine Release in the Nucleus Accumbens by Opiates, Alcohol, and Barbiturates: Studies with Transcerebral Dialysis in Freely Moving Rats , 1986, Annals of the New York Academy of Sciences.

[11]  M. Bozarth.  Neural basis of psychomotor stimulant and opiate reward: Evidence suggesting the involvement of a common dopaminergic system , 1986, Behavioural Brain Research.

[12]  G. Di Chiara,et al.  Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. , 1986, The Journal of pharmacology and experimental therapeutics.

[13]  M. Reith,et al.  Metaphit, a receptor acylator, inactivates cocaine binding sites in striatum and antagonizes cocaine-induced locomotor stimulation in rodents , 1986, Neuropharmacology.

[14]  F. Muntoni,et al.  Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area , 1985, Brain Research.

[15]  A. Thomson,et al.  An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? , 1985, Nature.

[16]  G. Di Chiara,et al.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  U. Ungerstedt,et al.  In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine , 1983, Journal of neurochemistry.

[18]  J. Km.  Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine. , 1983, Federation proceedings.

[19]  A. Phillips,et al.  Dopaminergic substrates of amphetamine-induced place preference conditioning , 1982, Brain Research.

[20]  K. Johnson,et al.  Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices. , 1982, The Journal of pharmacology and experimental therapeutics.

[21]  B. Westerink,et al.  On the Significance of Endogenous 3‐Methoxytyramine for the Effects of Centrally Acting Drugs on Dopamine Release in the Rat Brain , 1982, Journal of neurochemistry.

[22]  H. Meltzer,et al.  Phencyclidine as an indirect dopamine agonist [proceedings]. , 1980, Psychopharmacology bulletin.

[23]  H. Fibiger,et al.  Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens , 1980, Pharmacology Biochemistry and Behavior.

[24]  K. E. Moore,et al.  Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration , 1979, Pharmacology Biochemistry and Behavior.

[25]  M. Raiteri,et al.  Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. , 1979, The Journal of pharmacology and experimental therapeutics.

[26]  C. Braestrup.  Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats , 1977, The Journal of pharmacy and pharmacology.

[27]  H. Meltzer,et al.  Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain. , 1977, Biochemical pharmacology.

[28]  A. Pert,et al.  Neuroanatomical focus for morphine and enkaphalin-induced hypermotility , 1977, Nature.

[29]  R. Heath,et al.  The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes. , 1976, Life sciences.

[30]  S. Garattini,et al.  The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats. , 1975, European journal of pharmacology.

[31]  M. Raiteri,et al.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. , 1975, European journal of pharmacology.

[32]  U. Schacht,et al.  Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes. , 1974, Biochemical pharmacology.

[33]  R. Roth,et al.  Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. , 1973, The Journal of pharmacology and experimental therapeutics.

[34]  C. Schuster,et al.  Phencyclidine self-administration in the rhesus monkey , 1973 .

[35]  U. Ungerstedt.  Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.

[36]  W. Zeman.  The Rat Drain. A Stereotaxic Atlas , 1964 .

[37]  G. Di Chiara,et al.  Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  M. Raiteri,et al.  Release of Catecholamines, Serotonin, and Acetylcholine from Isolated Brain Tissue , 1984 .

[39]  B. McMillen.  CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs , 1983 .

[40]  R. Meisch,et al.  Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. , 1981, The Journal of pharmacology and experimental therapeutics.

[41]  R. Meisch,et al.  Drug Self-Administration: An Analysis of the Reinforcing Effects of Drugs , 1978 .

[42]  O. Lindvall,et al.  The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. , 1974, Acta physiologica Scandinavica. Supplementum.

[43]  T. Thompson,et al.  Self administration of and behavioral dependence on drugs. , 1969, Annual review of pharmacology.